Purigen Biosystems, Inc.


  • Webinars / Tutorials
    MAY 26 2022
    PRESENTATION: Full Presentation - ABRF 2022 Technology Showcase - K Rose and J Gu
    ABRF 2022 Technology Showcase with special guest speaker Dr. Jian Gu from the University of Texas, MD Anderson Cancer Center. This video discusses how the next-gen Ionic® Purification System enables pure nucleic acid extraction from FFPE samples using our proprietary charge-based isotachophoresis (ITP) technology.
  • Webinars / Tutorials
    JUL 28 2022
    PRESENTATION: Leveraging ITP-based Extraction to Improve Core Lab Operations and Increase Customer Satisfaction at MD Anderson Cancer Center - Dr. Jian Gu
    Dr. Jian Gu from The University of Texas, MD Anderson Cancer Center discusses how the next-gen Ionic® Purification System Improves core lab operations and increases customer satisfaction.
  • Webinars / Tutorials
    APR 21 2022
    WEBINAR: 01a - Maximizing DNA Yields from Peripheral Blood Mononuclear Cells for Archiving and NGS Analysis
    Peripheral Blood Mononuclear Cells (PBMCs) are a crucial sample type for a broad range of research applications including profiling immune cells and serving as “normal” controls for studies of FFPE tumor tissue for oncology studies. Maximizing the DNA yield from PBMCs enables archiving and increases the number of downstream assays that can be performed. The Ionic Purification System from Purigen Biosystems leverages isotachophoresis to maximize the yield of DNA from PBMCs. During the webinar data will be presented showing significantly improved yields of DNA extracted from PBMCs ranging in cell count from 10 cells to 5 million cells. Learning Objectives: • Learn how DNA yield and quality impact downstream genomic analysis • Understand how Isotachophoresis (ITP) works and enables superior nucleic acid extraction vs legacy technologies (columns, beads, precipitation, etc.) • Evaluate data showing superior yields from ITP-based extraction • Explore options for trying out ITP in your lab
  • Webinars / Tutorials
    MAR 12 2021
    WEBINAR: 01a - Simultaneous Extraction of DNA and RNA from FFPE Samples with 75% Less Hands-on Time
    The new Ionic® FFPE Complete Purification Kit from Purigen Biosystems provides simultaneous purification of DNA and RNA, including miRNA, from FFPE tissues. While most technologies use a serial approach to separately isolate DNA and RNA, this new kit enables a single, automated workflow using the Ionic® Purification System that requires 75% less hands on time.
  • Webinars / Tutorials
    OCT 06 2021
    WEBINAR: 01a - Unlock the Value in Your FFPE Samples - More Nucleic Acid with Less Hands-on Time Using Isotachophoresis
    FFPE tissue samples with a low abundance of nucleic acid continue to present a challenge for cancer genomics. Such samples frequently fail to produce sufficient DNA or RNA for downstream analyses, which can impact patient care or reduce the statistical power of a study. In this workshop, we will review data that demonstrates the ability of the Ionic® Purification System to recover sufficient yields of high-quality DNA, RNA, or miRNA from FFPE tissue samples that prove challenging for conventional methods.
  • Webinars / Tutorials
    NOV 19 2020
    WEBINAR: 01b - Automated Purification of DNA, RNA and miRNA from FFPE Tissue
    Researchers and clinicians continue to be challenged by FFPE tissue samples with a low abundance of high-quality nucleic acid. FFPE samples frequently fail to produce DNA or RNA with sufficient yield or quality for downstream analyses when conventional extraction methods are used. Despite efforts to optimize these labor-intensive extraction methods, extracts from FFPE samples frequently fail to qualify for next-generation sequencing or fail to yield actionable results when sequenced. In this webinar, we will review data from samples purified on the Ionic® Purification System that demonstrates the ability of the system to recover DNA, RNA, or miRNA from challenging FFPE tissue samples with sufficient yield and quality for downstream molecular analyses.